Abstract
PURPOSE: Changes in morbidity pattern of ulcerative colitis have created a need to update understanding of the course of the disease. METHOD: A follow-up study was done of relapse rates and progression of inflammation in 571 nonselected patients with ulcerative and indeterminate colitis. RESULTS: Relapse rate ten years after diagnosis was 70 percent in definite ulcerative colitis, 22 percent in probable ulcerative colitis, and 77 percent in indeterminate colitis. During the study period, there was no change in the relapse rate. In relapsing proctitis, 52 percent developed more extensive inflammation. Fifty-four percent of patients with only one attack of colitis had persistent signs of inflammatory bowel disease. CONCLUSIONS: Shift in morbidity pattern to a greater proportion of patients with proctitis at diagnosis and a shorter time from onset of symptoms to diagnosis had no influence on the relapse rate. Indeterminate colitis has a worse prognosis than definite ulcerative colitis. Considering the documented efficacy of sulfasalazine, the high relapse rate calls for studies of the effectiveness of such treatment in everyday practice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Broström O. Prognosis in ulcerative colitis. Med Clin North Am 1990;74:201–18.
Stewénius J, Adnerhill I, Ekelund G,et al. Ulcerative colitis and indeterminate colitis in the city of Malmö, Sweden, 1958 to 1982: a 25-year incidence study. Scand J Gastroenterol 1995;30:38–43.
Stewénius J, Adnerhill I, Andersson H,et al. Incidence of colorectal cancer and all cause mortality in nonselected patients with ulcerative colitis and indeterminate colitis. Int J Colorectal Dis 1995;10:117–22.
Stewénius J, Adnerhill I, Ekelund GR,et al. Surgical interventions in non-selected patients with ulcerative colitis and indeterminate colitis: a long term follow-up study (in press).
Evans JG, Acheson ED. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311–24.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis, final report on a therapeutic trial. BMJ 1955;2:1041–8.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–81.
Cox DR. Regression models and life-tables. J R Stat Soc 1972(B);34:187–220.
Softley A, Clamp SE, Watkinson G,et al. The natural history of inflammatory bowel disease: has there been a change in the last 20 years. Scand J Gastroenterol 1988;23(Suppl 144):20–3.
Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983;85:1–11.
Henriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis—based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158–63.
Samuelsson S-M. Ulcerative colitis in the county of Uppsala: clinical, epidemiological and sociomedical aspects (thesis). University of Uppsala, Sweden, 1976. ISBN 91-554-0421-9.
Tysk C, Järnerot G. Ulcerative proctocolitis in Örebro, Sweden: a retrospective epidemiological study, 1963–1987. Scand J Gastroenterol 1992;27:945–50.
Stonnington CM, Phillips SF, Zinsmeister AR, Melton LJ III. Prognosis of chronic ulcerative colitis in a community. Gut 1987;28:1261–6.
Powell-Tuck J, Ritchie JK, Lennard-Jones JE. The prognosis of idiopathic proctitis. Scand J Gastroenterol 1977;12:727–32.
Misiewicz JJ, Lennard-Jones JE, Connell AM,et al. Controlled trial of sulphasalazine in maintenance therapy for ulcerative colitis. Lancet 1965;1:185–8.
Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin). Gut 1973;14:923–6.
Author information
Authors and Affiliations
Additional information
Supported by grants from the Swedish Cancer Society (Project 1353 B91 01 X AB), “Förenade Liv” Mutual Group Life Insurance Company, Stockholm, Sweden, Tika Läkemedel AB, Sweden, Malmö University Hospital, and Lund University.
About this article
Cite this article
Stewénius, J., Adnerhill, I., Ekelund, G.R. et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum 39, 1019–1025 (1996). https://doi.org/10.1007/BF02054693
Issue Date:
DOI: https://doi.org/10.1007/BF02054693